Research Article
Improved Medication Adherence with the Use of Extended-Release Tacrolimus in Liver Transplant Recipients: A Pilot Randomized Controlled Trial
Table 2
PROMIS-29 scores, baseline, and mean throughout the study.
| | | TAC-ER (n = 9) | TAC-IR (n = 16) | value |
| Fatigue, mean (SD) | Baseline | 51.1 (14.2) | 47.4 (9.1) | 0.44 | Week 4-month 9 | 55.7 (9.7) | 51.4 (7.7) | 0.23 |
| Sleep disturbance, mean (SD) | Baseline | 54.3 (4.2) | 51.2 (3.6) | 0.069 | Week 4-month 9 | 52.4 (2.4) | 52.4 (1.7) | 0.99 |
| Anxiety, mean (SD) | Baseline | 52.2 (12.1) | 47.3 (7.2) | 0.23 | Week 4-month 9 | 56.2 (11.2) | 50.1 (7.8) | 0.12 |
| Depression, mean (SD) | Baseline | 50.4 (10.3) | 45.6 (5.8) | 0.16 | Week 4-month 9 | 54.1 (10.5) | 48.9 (5.9) | 0.13 |
| Physical function, mean (SD) | Baseline | 29.1 (7.0) | 28.3 (5.6) | 0.77 | Week 4-month 9 | 28.6 (8.0) | 29.9 (6.6) | 0.67 |
| Social roles, mean (SD) | Baseline | 41.4 (9.2) | 27.0 (8.3) | 0.24 | Week 4-month 9 | 41.7 (9.2) | 38.6 (7.5) | 0.38 |
| Pain interference, mean (SD) | Baseline | 52.9 (11.8) | 51.9 (10.7) | 0.84 | Week 4-month 9 | 50.6 (10.3) | 51.5 (10.4) | 0.83 |
| Pain intensity, mean (SD) | Baseline | 3.5 (3.9) | 2.9 (3.9) | 0.70 | Week 4-month 9 | 3.1 (3.2) | 3.2 (2.8) | 0.92 |
|
|